Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Lyka Labs Ltd

NSE: LYKALABS · BSE: 500259 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹74.85
Market cap
₹267.1 Cr
Revenue (annual)
₹128.4 Cr
Net profit (annual)
₹-10.03 Cr
P/E (TTM)
-30.0×Sector 47.4×
Promoter holding
58.45%+0.29% QoQ
FII holding
0.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:46 IST BSE
Other Announcement

Lyka Labs Other Announcement

Lyka Labs allotted 462,711 equity shares following an NCLT-approved amalgamation with Lyka Exports, as disclosed in this quarterly shareholding pattern filing.

17:26 IST BSE
Other Announcement

Lyka Labs Other Announcement

Lyka Labs Limited declared that it does not fall under the 'Large Corporate' category as of March 31, 2026, per SEBI guidelines. Consequently, the mandatory requirement for incremental borrowing through debt securities is not applicable. The company reported outstanding long-term borrowings of Rs. 20.15 Crore and maintains a BBB+ credit rating.

13:21 IST NSE
Other Announcement

Lyka Labs Other Announcement

Lyka Labs Limited has submitted the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2026. The certificate, issued by MUFG Intime India Private Limited, confirms the processing of dematerialisation requests within prescribed timelines.